-+ 0.00%
-+ 0.00%
-+ 0.00%

*Adicet Bio to Request FDA Meeting in 1Q/2026 to Inform Potentially Pivotal ADI-001 Trial Design

Dow Jones·11/05/2025 21:15:00

Please log in to view news